<div><p>HIV-1 entry into host cells is mediated by interactions between the V3-loop of viral glycoprotein gp120 and chemokine receptor CCR5 or CXCR4, collectively known as HIV-1 coreceptors. Accurate genotypic prediction of coreceptor usage is of significant clinical interest and determination of the factors driving tropism has been the focus of extensive study. We have developed a method based on nonlinear support vector machines to elucidate the interacting residue pairs driving coreceptor usage and provide highly accurate coreceptor usage predictions. Our models utilize centroid-centroid interaction energies from computationally derived structures of the V3-loop:coreceptor complexes as primary features, while additional features based on...
The ability to determine coreceptor usage of patient-derived human immunodeficiency virus type 1 (HI...
Background: CCR5-coreceptor antagonists can be used for treating HIV-2 infected individuals. Before ...
\sectionMotivation:} Due to the high mutation rate of HIV, drug resistant variants emerge frequently...
HIV-1 cell entry commonly uses, in addition to CD4, one of the chemokine receptors CCR5 or CXCR4 as ...
HIV-1 cell entry commonly uses, in addition to CD4, one of the chemokine receptors CCR5 or CXCR4 as ...
HIV-1 cell entry commonly uses, in addition to CD4, one of the chemokine receptors CCR5 or CXCR4 as...
<div><p>Background</p><p>HIV-1 infects the host cell by interacting with the primary receptor CD4 an...
Background. Human immunodeficiency virus type 1 (HIV-1) uses the CD4 receptor and a coreceptor to ga...
<div><p>The relationship of HIV tropism with disease progression and the recent development of CCR5-...
BACKGROUND: The interaction between HIV-1 gp120 and CCR5 N terminus is critical for R5-virus entry ...
Human immunodeficiency virus type 1 (HIV-1) isolates differ in their use of coreceptors to enter tar...
Human immunodeficiency virus type 1 (HIV-1) isolates differ in their use of coreceptors to enter tar...
Early in infection, human immunodeficiency virus type 1 (HIV-1) generally uses the CCR5 chemokine re...
The ability to determine coreceptor usage of patient-derived human immunodeficiency virus type 1 (HI...
<div><p>The ability to determine coreceptor usage of patient-derived human immunodeficiency virus ty...
The ability to determine coreceptor usage of patient-derived human immunodeficiency virus type 1 (HI...
Background: CCR5-coreceptor antagonists can be used for treating HIV-2 infected individuals. Before ...
\sectionMotivation:} Due to the high mutation rate of HIV, drug resistant variants emerge frequently...
HIV-1 cell entry commonly uses, in addition to CD4, one of the chemokine receptors CCR5 or CXCR4 as ...
HIV-1 cell entry commonly uses, in addition to CD4, one of the chemokine receptors CCR5 or CXCR4 as ...
HIV-1 cell entry commonly uses, in addition to CD4, one of the chemokine receptors CCR5 or CXCR4 as...
<div><p>Background</p><p>HIV-1 infects the host cell by interacting with the primary receptor CD4 an...
Background. Human immunodeficiency virus type 1 (HIV-1) uses the CD4 receptor and a coreceptor to ga...
<div><p>The relationship of HIV tropism with disease progression and the recent development of CCR5-...
BACKGROUND: The interaction between HIV-1 gp120 and CCR5 N terminus is critical for R5-virus entry ...
Human immunodeficiency virus type 1 (HIV-1) isolates differ in their use of coreceptors to enter tar...
Human immunodeficiency virus type 1 (HIV-1) isolates differ in their use of coreceptors to enter tar...
Early in infection, human immunodeficiency virus type 1 (HIV-1) generally uses the CCR5 chemokine re...
The ability to determine coreceptor usage of patient-derived human immunodeficiency virus type 1 (HI...
<div><p>The ability to determine coreceptor usage of patient-derived human immunodeficiency virus ty...
The ability to determine coreceptor usage of patient-derived human immunodeficiency virus type 1 (HI...
Background: CCR5-coreceptor antagonists can be used for treating HIV-2 infected individuals. Before ...
\sectionMotivation:} Due to the high mutation rate of HIV, drug resistant variants emerge frequently...